SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-001444
Filing Date
2022-01-21
Accepted
2022-01-21 17:10:09
Documents
1
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3490
  Complete submission text file 0001567619-22-001444.txt   4971
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 RAILROAD AVE. GREENWICH CT 06830
Business Address 55 RAILROAD AVE. GREENWICH CT 06830 205-863-5000
DRAGSA 96 LLC (Reporting) CIK: 0001904854 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41199 | Film No.: 22546702